Objective-To assess the relation between two risk factors for cervical neoplasia: smoking and infection with oncogenic human papillomavirus. It 
Introduction
Cervical intraepithelial neoplasia is a morphologically defined lesion associated with the development of cervical carcinoma and is conventionally separated into three grades according to the severity of cytological abnormality and disturbance of the epithelial architecture.' It has been established that cervical infection with human papillomavirus is important in the aetiology of neoplasia.
Human papillomavirus shows considerable genetic heterogeneity, and the list of different types is growing.2 A subset of the virus types, called the oncogenic types, includes types 16, 18, and 33 and is found in 80-90% of cervical carcinomas. Of carcinomas positive for human papillomavirus, types 16 and 18 account for about 90%.3 Compared with invasive carcinoma, intraepithelial neoplastic lesions harbour a greater diversity of human papillomavirus types. 4 The benign types, 6 and 1 1, are found in condylomas and low grade intraepithelial neoplasia but are seldom if ever the only virus types in invasive carcinomas.5 The malignant potential of many other virus types mainly found in association with mild to moderate dysplastic smears is uncertain. 4 Cigarette smoking is a risk factor for cervical neoplasia.6 It has been associated with the presence of cervical human papillomavirus in patients at student health clinics.7 Another risk factor for cervical neoplasia is sexual behaviour: a woman's having intercourse before the age of 17 was the most powerfully discriminating variable in nearly all the studies where this has been investigated, and a history of multiple sexual partners is an important supporting variable.8
The association between smoking and cervical neoplasia, however, remains after adjustment has been made for such sexual risk factors.9'-2
We performed a cross-sectional epidemiological study on 181 women with a report of cervical cytological abnormality in order to find out whether the presence of oncogenic human papillomavirus was associated with the grade of the neoplastic lesion; whether smoking was associated with the grade of the neoplastic lesion; and whether smoking was associated with the presence of oncogenic human papillomavirus.
Patients and methods

PATIENTS
We recruited patients from the outpatient clinic of the department of gynaecology, University Hospital, Groningen. Some had been referred by their general practitioners because of a report of cervical cytological abnormality, and in others a cytological abnormality had been discovered during gynaecological examination. Patients were eligible for participation in the study if two cervical smears indicated mild or moderate dysplasia or one smear indicated severe dysplasia or carcinoma in situ. These cytological criteria for eligibility correspond with the grounds for colposcopy as agreed by cytopathologists and gynaecologists in the Netherlands.
The interval between the two smears indicating mild or moderate dysplasia was a maximum of one year. We requested smears that had not been initially examined at our cytology department for review, and our cytologist's readings were definitive. Patients were ineligible if they had previously undergone a colposcopic examination because of a report of abnormal cytology, if their cervical smear was taken during pregnancy, or if their cervical smear indicated atypical endocervical cylindrical epithelium.
From 1 September 1988 to 1 May 1991, 194 consecutive patients were eligible for participation in the study and were invited to the outpatient clinic for an extra visit to answer a structured questionnaire and to have a cervical scrape taken for analysis for human papillomavirus. Thirteen patients did not enter the study: two did not want to, two were pregnant at the time of colposcopy, and nine were not treated in accordance with the study protocol (no cervical scrape or no biopsy specimen was taken or no treatment was given when the biopsy specimen showed cervical intraepithelial neoplasia). Therefore, 181 patients were included in the study. QUESTIONNAIRE We asked the women the average number of cigarettes they smoked a day and asked those who did not smoke whether they had ever smoked at least 10 cigarettes a day. We also asked the patients their age at their first sexual intercourse and their lifetime number of sexual partners. We had told the women beforehand that the questionnaire contained intimate questions and that they were not obliged to answer.
ANALYSIS FOR HUMAN PAPILLOMAVIRUS
We scraped the cervix with the blunt and pointed ends of a wooden cervical spatula and with an endocervical brush. We suspended the scraped cells in 5 ml phosphate buffered saline, pH 7-2, supplemented with merthiolate 1:10000 vol/vol and sent the cell suspension to the laboratory for processing the next morning. The polymerase chain reaction was performed for human papillomavirus types 6 and 1 1, 16, 18, and 33 as described previously.'3"' The laboratory staff were unaware of the histological reports.
MORPHOLOGICAL EXAMINATION
Four weeks after the cervix had been scraped, we took colposcopically directed biopsy specimens and, in the case of an endocervical position of the neosquamocolumnar junction, performed endocervical curettage. If cervical intraepithelial neoplasia was diagnosed from the tissue specimens we excised the whole transformation zone about 4-6 weeks later by low voltage diathermy ablation or cold knife conisation. The diathermy loop was used when the neosquamocolumnar junction could be visualised entirely and did not extend up into the canal more than 5 mm from the anatomical os extemum.
One pathologist who was unaware of the virus types found in the cervical scrapes examined all the biopsy specimens and the excised tissues from the patients. Cervical (11) . The patients were aged 20-67 with a mean age of 34-4 (SD 7 9) years. There was no difference between the categories of the diagnosis with regard to age distribution (X2=3-1 1, df=4, p=0 54; Kruskal-Wallis one way analysis of variance).
HUMAN PAPILLOMAVIRUS AND CERVICAL NEOPLASIA BMJ VOLUME 306 20 MARCH 1993 cantly in accordance with the number of cigarettes smoked a day. We analysed the dose-response relation with adjustment for the patients' age at first intercourse and lifetime number of sexual partners. Nine patients did not give their number of sexual partners and one of them did not tell her age at first intercourse. We therefore performed the analysis on 172 patients: the median age at first intercourse was 17 (interquartile range [16] [17] [18] [19] years, and the median number of sexual partners was 4 (interquartile range 2-10) partners. For the analysis we grouped patients according to age at first intercourse ( S 17 or > 18) and lifetime number of sexual partners (1-2, 3-4, 5-10, and : 11). After adjustment for these sexual risk factors we found that the dose-response relation between the number of cigarettes smoked a day and the presence of oncogenic human papillomavirus was still significant (x2= 10-90, df= 1, p < 0001).
We also investigated whether this dose-response relation depended on the histological severity of the lesion. Since we had found that the analysis was hardly affected by adjustment for sexual risk factors we performed a non-adjusted analysis on the entire group of 181 women. We grouped patients into those with no or low grade lesions (up to and including cervical intraepithelial neoplasia grade II) and those with more severe lesions (cervical intraepithelial neoplasia grade III or microinvasive carcinoma). Table III shows that the dose-response relation between the number of cigarettes smoked a day and the occurrence of oncogenic human papillomavirus in the cervix was significant in both groups. :X2=4-30, df= 1. §X2 =6-11, df= 1.
Of the 63 women who did not smoke, 23 women had smoked at least 10 cigarettes a day at some time. Of these 23 women, 14 (61%) had oncogenic human papillomavirus in their cervix. Of the remaining 40 women who did not currently smoke and who had never smoked at least 10 cigarettes a day, only 12 (30%) had oncogenic papillomavirus. This difference was statistically significant (x2=4-54, df=l, p=0033; X2 test for two proportions).
Discussion
We studied only newly diagnosed cases of cervical abnormality because the persistence or recurrence of cervical neoplasia might also be affected by the factors under study. Pregnant patients were excluded because biopsy and treatment are usually postponed until after delivery. Because of possible biological differences in the development of squamocellular and adenocellular cervical neoplasia we also excluded any patients with atypical endocervical cylindrical cells in the smear. For the detection and typing of human papillomavirus we used cervical scrapes instead of biopsy specimens. In situ hybridisation studies have shown that human papillomavirus can be detected only within lesions and not in adjacent normal epithelium.6 '7 The probability of missing a cervical infection is possibly higher when using biopsy specimens because of inevitable sampling errors. Our data cannot be compared directly to those of other investigators because the reported frequencies of human papillomavirus in cervical lesions vary widely because of differences in selecting patients, in the materials analysed, in detection techniques, and in the geographical occurrence of virus types.'8 The frequencies of the virus types observed in our patient group match the findings of another group of Dutch investigators. 4 We found that 80/102 (78%) patients positive for oncogenic human papillomavirus had cervical intraepithelial neoplasia grade III or a more severe lesion. Since patients with all three grades of cervical intraepithelial neoplasia had similar ages this suggests that many infections with oncogenic human papillomavirus apparently led directly to cervical intraepithelial neoplasia grade III. Campion et al suggested that human papillomavirus infections progress rapidly from grade I to grade III of cervical intraepithelial neoplasia,"' but their study was methodologically flawed in that grade I lesions were diagnosed by colposcopy while grade III lesions were later diagnosed by histology. The features that can be seen by colposcopy do not, however, correspond well with the severity of histological abnormality.>0
We found that 65% of the patients smoked at least one cigarette a day, a proportion nearly twice as high as that in the general population. According to Dutch health statistics from 1990, 38% of women aged 20- We did not find an association between smoking and the grade of cervical intraepithelial neoplasia, and so our data do not support the hypothesis that cigarette smoke has a direct mutagenic effect on the cervical epithelium. We did, however, find a significant doseresponse relation between the number of cigarettes smoked daily and the presence of oncogenic human papillomavirus in the cervical lesion. Such a graded response according to exposure can strengthen inferences of causality.2' The relation remained after adjustment for sexual risk factors, indicating a significant independent effect of smoking. We also found that the presence of human papillomavirus in the cervix of nonsmokers was significantly associated with a history of smoking. Our findings support the suggestion that smoking might produce a local immunological defect, which could facilitate the infection and persistence of human papillomavirus.24
The dose-response relation between the number of cigarettes smoked daily and the presence of oncogenic human papillomavirus was found both in the group with no or low grade lesions and in the group with more severe lesions. This confirms that lesions associated with one particular virus type may show diverse morphological characteristics. Possible explanations for this diversity are the physical state of the virus (whether it is extrachromosomal or integrated into the host cell chromosomes),> the topographical BMJ VOLUME 306 position of the lesion on the cervix,27 and the presence of possible cofactors such as herpes viruses in carcinogenesis. I Richart RM. Cervical intraepithelial neoplasia: a review. In: Sommers SC, ed.
Introduction
Chemotherapeutic management of advanced colorectal cancer has been a challenge to medical oncologists for the past three decades. Although tumours in 15-20% of patients have responded to fluorinated pyrimidines, in particular 5-fluorouracil, there has been no evidence of improved survival.' Empirically derived combinations of chemotherapeutic drugs have given disappointing results.2 Recent attempts to enhance the therapeutic activity of 5-fluorouracil have focused on biochemical modulation: several randomised studies have shown that its effect is greater when used in combination with leucovorin. 3 The optimal dose, schedule, and route of administration, however, have not been established. Complete response is rare, and the improvement in median survival seems small. Furthermore, most 5-fluorouracil and leucovorin dose schedules have a high incidence of severe gastrointestinal side effects3 and may thus interfere with the patients' quality of life, one of the most important aspects to be considered in palliative treatment.
Because of uncertainty about the true palliative benefit of combined regimens we conducted a randomised study of the effects of chemotherapy and supportive care on survival and quality of life of patients with colorectal cancer. The chemotherapeutic regimen chosen was a combination of 5-fluorouracil and leucovorin with cisplatin. Cisplatin was included 752 BMJ VOLUME 306
